2021-07-16

New glaucoma genetic test will increase the likelihood of finding high-risk patients 15 times

By yqqlm yqqlm

New glaucoma genetic test will increase the likelihood of finding high-risk patients 15 times

From Flinders University in South Australia and New Associate Professor Owen Siggs, the lead researcher of the Gavin Institute of Medical Research in Sydney, South Wales, said: “Early diagnosis of glaucoma can lead to vision-saving treatment, and genetic information may give us the advantage of early diagnosis and make more changes. Good treatment decision.”

Senior author, Flinders University professor Jamie Craig said that the latest research highlights the test’s potential for glaucoma screening and management.

“Gene testing is currently not a routine part of glaucoma diagnosis and care, but this type of test may change this situation.” Professor Craig said: “We are now able to start testing in clinical trials.” He is an ophthalmology consultant and also manages a world-leading glaucoma research project at Flinders University, which is funded by the Australian National Health and Research Council.

New glaucoma genetic test will increase the likelihood of finding high-risk patients 15 times(1)

The latest results on 2507 Australians The genetic test performance of glaucoma patients and 411,337 British glaucoma patients was benchmarked.

One out of every 30 Australians will eventually develop glaucoma, and many of them are diagnosed as late due to lack of symptoms. Once diagnosed, several treatment options can slow or stop the development of glaucoma vision loss.

New tests performed on blood or saliva samples may identify high-risk individuals before irreversible vision loss occurs. Members of the research team are also setting up a spin-off company to develop accredited tests for clinical trials, and recruitment is expected to begin in 2022.